- Stage 1: Discovery and Development
- Stage 2: Preclinical Research
- Stage 3: Clinical Development
- Stage 4: FDA Review
- Stage 5: Post-market Monitoring
Other Relevant Drug Development Concepts
The intricacy in drug improvement has expanded manifolds in the course of recent years, requiring preclinical testing, investigational new medication (IND) applications, and finished clinical testing prior to showcasing endorsement from the FDA. By and large, new medication applications (NDAs) or biologics permit applications (BLA) are checked on thoroughly before endorsement, and afterward drug execution is resubmitted to administrative organizations for post-showcasing contemplates. The overall objective is to carry more effective and more secure therapies to the patients as fast as conceivable after an intensive clinical assessment.